Literature DB >> 11579356

Hematocrit and the risk of coronary heart disease mortality.

D W Brown1, W H Giles, J B Croft.   

Abstract

BACKGROUND: An association between hematocrit (Hct) and coronary heart disease (CHD) mortality has been previously observed. However, the relationship of Hct and CHD independent of other cardiovascular disease (CVD) risk factors and differences between men and women remain unclear.
METHODS: We examined the association between Hct and CHD mortality with Cox regression analyses of data from 8896 adults, aged 30-75 years, in the Second National Health and Nutrition Examination Survey (NHANES II) Mortality Study (1976-1992). Covariates included age, sex, race, education, smoking status, hypertensive status, total serum cholesterol, body mass index, white blood cell count, and history of CVD and diabetes. Hct was categorized by use of sex-specific tertiles, and all analyses were stratified by sex.
RESULTS: During 16.8 years of follow-up, there were 545 (men 343, women 202) deaths from CHD (International Classification of Diseases, 9th revision [ICD-9] 410-414), 778 (men 426, women 279) deaths from diseases of the heart (ICD-9 390-398, 402, 404, 410-414, 415-417, 420-429), and 2046 (men 1216, women 830) all-cause deaths. Among men, the crude CHD mortality rate per 10,000 population was 42.6, 31.9, and 46.3 among those with Hct in the lower, middle, and upper tertiles, respectively. The corresponding crude CHD mortality rates among women were 12.6, 18.6, and 27.7. After adjustment for age and other CVD risk factors, there was no association between Hct in the upper tertile compared with the lower tertile and mortality from either CHD, diseases of the heart, or all causes among men. Women with Hct in the upper tertile were 1.3 times (95% CI 0.9-1.9) more likely to die from CHD than were women with Hct in the lowest tertile, after multivariate adjustment. The effect of high Hct on CHD mortality among women younger than 65 years of age was slightly stronger (relative risk 2.2, 95% CI 1.0-4.6).
CONCLUSIONS: These results suggest that the association between Hct and mortality from CHD and all causes is complex, differing both by sex and age. Further research is needed to gain a better understanding of these age and sex differences.

Entities:  

Mesh:

Year:  2001        PMID: 11579356     DOI: 10.1067/mhj.2001.118467

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  27 in total

Review 1.  Androgens and male aging: Current evidence of safety and efficacy.

Authors:  Louis J Gooren
Journal:  Asian J Androl       Date:  2010-02-15       Impact factor: 3.285

Review 2.  Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update.

Authors:  Mohammad Madjid; Omid Fatemi
Journal:  Tex Heart Inst J       Date:  2013

3.  A U-shaped relationship between haematocrit and mortality in a large prospective cohort study.

Authors:  Paolo Boffetta; Farhad Islami; Rajesh Vedanthan; Akram Pourshams; Farin Kamangar; Hooman Khademi; Arash Etemadi; Rasool Salahi; Shahryar Semnani; Ashkan Emadi; Christian C Abnet; Paul Brennan; Paul D Pharoah; Sanford M Dawsey; Reza Malekzadeh
Journal:  Int J Epidemiol       Date:  2013-04       Impact factor: 7.196

4.  Hemoglobin concentration and risk of arterial and venous thrombosis in 1.5 million Swedish and Danish blood donors.

Authors:  Malin Hultcrantz; Anton Modlitba; Senthil K Vasan; Arvid Sjölander; Klaus Rostgaard; Ola Landgren; Henrik Hjalgrim; Henrik Ullum; Christian Erikstrup; Sigurdur Y Kristinsson; Gustaf Edgren
Journal:  Thromb Res       Date:  2019-12-20       Impact factor: 3.944

5.  Sex-specific associations between erythrocyte measures and obstructive sleep apnea.

Authors:  Taomei Li; Naima Covassin; Lu Tan; Rong Ren; Ye Zhang; Fei Lei; Linghui Yang; Junying Zhou; Hongqiang Sun; Virend K Somers; Xiangdong Tang
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

6.  Hemoglobin concentration and incident metabolic syndrome: a population-based large-scale cohort study.

Authors:  Yoshitaka Hashimoto; Muhei Tanaka; Toshihiro Kimura; Noriyuki Kitagawa; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Yohei Oda; Hitoshi Toda; Naoto Nakamura; Michiaki Fukui
Journal:  Endocrine       Date:  2015-04-12       Impact factor: 3.633

7.  Excessive erythrocytosis compromises the blood-endothelium interface in erythropoietin-overexpressing mice.

Authors:  Vincent Richter; Michele D Savery; Max Gassmann; Oliver Baum; Edward R Damiano; Axel R Pries
Journal:  J Physiol       Date:  2011-08-22       Impact factor: 5.182

8.  Anaemia predicts cardiovascular events in patients with stable coronary artery disease.

Authors:  E Lips̆ic; F W Asselbergs; P van der Meer; R A Tio; A A Voors; W H van Gilst; F Zijlstra; D J van Veldhuisen
Journal:  Neth Heart J       Date:  2005-08       Impact factor: 2.380

Review 9.  Androgens and erythropoiesis: past and present.

Authors:  S Shahani; M Braga-Basaria; M Maggio; S Basaria
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

Review 10.  The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes.

Authors:  Yi-Da Tang; Stuart D Katz
Journal:  Heart Fail Rev       Date:  2008-02-02       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.